Mir-302a-3p promotes radiotherapy sensitivity of hepatocellular carcinoma by regulating cell cycle via mcl1

HIGHLIGHTS

• who: Zifeng Yang and collaborators from the Department of Interventional Radiology, The Fifth People`s Hospital of Jinan, Jinan, Shandong, China Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China have published the research work: miR-302a-3p Promotes Radiotherapy Sensitivity of Hepatocellular Carcinoma by Regulating Cell Cycle via MCL1, in the Journal: Computational and Mathematical Methods in Medicine of 10/Oct/2022
• what: This study preliminarily explored the potential impact and mechanism of miR-302a-3p on HCC radiotherapy resistance.
• how: These results indicated that overexpression of miR . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.